7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15/month, without ads. Start a trial. Go ad free!
BBH vs FBT
Both BBH and FBT are ETFs. BBH has a lower 5-year return than FBT (9.1% vs 11.37%). BBH has a lower expense ratio than FBT (0.35% vs 0.55%). Below is the comparison between BBH and FBT.
| BBH | FBT | |
|---|---|---|
| Segment | Equity: Global Biotech | Equity: U.S. Biotech |
| Issuer | VanEck | First Trust |
| Net Assets | $478.8M | $2.04B |
| Expense Ratio | 0.35% | 0.55% |
| Management Style | passive (index-based) | passive (index-based) |
| Dividend Yield | 0.36% | 0.00% |
| Underlying Index | MVIS US Listed Biotech 25 Index | NYSE Arca Biotechnology Index |
| YTD Return | 3.49% | 3.92% |
| 1-Year Return | 25.76% | 16.33% |
| 3-Year Return | 11.90% | 11.38% |
| 5-Year Return | 9.10% | 11.37% |
| 10-Year Return | N/A | 16.08% |
BBH description
The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.
BBH performance & returns
| YTD Return | 3.49% |
| 1-Month Return | 1.50% |
| 3-Month Return | 6.05% |
| 1-Year Return | 25.76% |
| 3-Year Return | 11.90% |
| 5-Year Return | 9.10% |
| 10-Year Return | N/A |
BBH expense ratio is 0.35%.
BBH holdings
Top 10 Holdings (61.45% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Amgen Inc | AMGN | 14.27% |
| Gilead Sciences Inc | GILD | 7.23% |
| Moderna Inc | MRNA | 5.48% |
| Regeneron Pharmaceuticals Inc | REGN | 5.47% |
| Exact Sciences Corp | EXAS | 5.28% |
| Alexion Pharmaceuticals Inc | ALXN | 4.92% |
| IQVIA Holdings Inc | IQV | 4.91% |
| Biogen Inc | BIIB | 4.75% |
| Vertex Pharmaceuticals Inc | VRTX | 4.59% |
| Illumina Inc | ILMN | 4.55% |
Other relevant BBH comparisons
You may also want to check out the following BBH comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
FBT description
The Fund seeks investment results that correspond generally to the price and yield of an equity index called the NYSE Arca Biotechnology Index. The Fund normally invests at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the Index.
FBT performance & returns
| YTD Return | 3.92% |
| 1-Month Return | 7.10% |
| 3-Month Return | 7.08% |
| 1-Year Return | 16.33% |
| 3-Year Return | 11.38% |
| 5-Year Return | 11.37% |
| 10-Year Return | 16.08% |
FBT expense ratio is 0.55%.
FBT holdings
Top 10 Holdings (36.20% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Exact Sciences Corp | EXAS | 4.07% |
| United Therapeutics Corp | UTHR | 3.95% |
| ACADIA Pharmaceuticals Inc | ACAD | 3.85% |
| Agios Pharmaceuticals Inc | AGIO | 3.78% |
| Ultragenyx Pharmaceutical Inc | RARE | 3.59% |
| Ionis Pharmaceuticals Inc | IONS | 3.45% |
| Sarepta Therapeutics Inc | SRPT | 3.43% |
| Neurocrine Biosciences Inc | NBIX | 3.37% |
| Illumina Inc | ILMN | 3.36% |
| Bio-Techne Corp | TECH | 3.35% |
Other relevant FBT comparisons
You may also want to check out the following FBT comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
